APA

Dai W. F., Beca J. M., Croxford R., Isaranawatchai W., Menjak I. B., Petrella T. M., Mittmann N., Earle C. C., Gavura S., Hanna T. P. & Chan K. K. W. (20201218). Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada. : BMC cancer.

Chicago

Dai Wei Fang, Beca Jaclyn M, Croxford Ruth, Isaranawatchai Wanrudee, Menjak Ines B, Petrella Teresa M, Mittmann Nicole, Earle Craig C, Gavura Scott, Hanna Timothy P and Chan Kelvin K W. 20201218. Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada. : BMC cancer.

Harvard

Dai W. F., Beca J. M., Croxford R., Isaranawatchai W., Menjak I. B., Petrella T. M., Mittmann N., Earle C. C., Gavura S., Hanna T. P. and Chan K. K. W. (20201218). Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada. : BMC cancer.

MLA

Dai Wei Fang, Beca Jaclyn M, Croxford Ruth, Isaranawatchai Wanrudee, Menjak Ines B, Petrella Teresa M, Mittmann Nicole, Earle Craig C, Gavura Scott, Hanna Timothy P and Chan Kelvin K W. Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada. : BMC cancer. 20201218.